Article: Advanced Viral Research Corp. Announces Research Agreement With The Weizmann Institute Of Science.

- Scientists at Weizmann Institute of Science to Study Company's

Flagship,Broad-Spectrum Immunomodulator, Product R -

YONKERS, N.Y., Feb. 1 /PRNewswire/ --

Shalom Z. Hirschman, M.D., President and C.E.O. of Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), today announced a research agreement with the world-renowned Weizmann Institute of Science and with YEDA, its developmental arm, both located in Rehovot, Israel, to study the immunological effects of Product R, Advanced Viral Research Corp.'s flagship immunomodulator and antiviral drug.

Scientists in the Department of Immunology at The Weizmann Institute of Science, under the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!